Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.04
0.000.00%
At close: -
$2.98
-0.06-1.97%
After Hours: Jun 18, 7:14 PM EDT
Comments
Loading...
Sophia Genetics Analyst Ratings and Price Targets | NASDAQ:SOPH | Benzinga
Sophia Genetics SA has a consensus price target of $7 based on the ratings of 7 analysts. The high is $11 issued by Craig-Hallum on December 18, 2024. The low is $2 issued by Credit Suisse on November 23, 2022. The 3 most-recent analyst ratings were released by Craig-Hallum, RBC Capital, and Guggenheim on December 18, 2024, August 7, 2024, and June 27, 2024, respectively. With an average price target of $8 between Craig-Hallum, RBC Capital, and Guggenheim, there's an implied 168.46% upside for Sophia Genetics SA from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
RBC Capital
Guggenheim
BTIG
Credit Suisse
1calculated from analyst ratings
Analyst Ratings for Sophia Genetics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 12/18/2024 | Buy Now | 269.13% | Craig-Hallum | — | → $11 | Initiates | → Buy | Get Alert |
| 08/07/2024 | Buy Now | 134.9% | RBC Capital | Conor McNamara36% | $8 → $7 | Maintains | Outperform | Get Alert |
| 06/27/2024 | Buy Now | 101.34% | Guggenheim | Subbu Nambi49% | → $6 | Initiates | → Buy | Get Alert |
| 03/06/2024 | Buy Now | 168.46% | RBC Capital | Conor McNamara36% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 03/06/2024 | Buy Now | 168.46% | BTIG | Mark Massaro71% | $7 → $8 | Maintains | Buy | Get Alert |
| 01/12/2024 | Buy Now | 168.46% | RBC Capital | Conor McNamara36% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert |
| 11/29/2023 | Buy Now | 168.46% | RBC Capital | Conor McNamara36% | → $8 | Initiates | → Outperform | Get Alert |
| 05/10/2023 | Buy Now | 67.79% | Credit Suisse | Rich Hilliker62% | $2.25 → $5 | Maintains | Neutral | Get Alert |
| 05/10/2023 | Buy Now | 235.57% | Morgan Stanley | Tejas Savant51% | $11 → $10 | Maintains | Overweight | Get Alert |
| 03/08/2023 | Buy Now | 269.13% | Morgan Stanley | Tejas Savant51% | $12 → $11 | Maintains | Overweight | Get Alert |
| 01/03/2023 | Buy Now | 101.34% | BTIG | Mark Massaro71% | → $6 | Initiates | → Buy | Get Alert |
| 11/23/2022 | Buy Now | -32.89% | Credit Suisse | Phil Winslow42% | → $2 | Initiates | → Neutral | Get Alert |
| 11/09/2022 | Buy Now | 302.68% | Morgan Stanley | Tejas Savant51% | $13 → $12 | Maintains | Overweight | Get Alert |
| 08/10/2022 | Buy Now | 336.24% | Morgan Stanley | Tejas Savant51% | $14 → $13 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Sophia Genetics (SOPH) stock?
The latest price target for Sophia Genetics (NASDAQ:SOPH) was reported by Craig-Hallum on December 18, 2024. The analyst firm set a price target for $11.00 expecting SOPH to rise to within 12 months (a possible 269.13% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sophia Genetics (SOPH)?
The latest analyst rating for Sophia Genetics (NASDAQ:SOPH) was provided by Craig-Hallum, and Sophia Genetics initiated their buy rating.
When was the last upgrade for Sophia Genetics (SOPH)?
There is no last upgrade for Sophia Genetics
When was the last downgrade for Sophia Genetics (SOPH)?
There is no last downgrade for Sophia Genetics.
When is the next analyst rating going to be posted or updated for Sophia Genetics (SOPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sophia Genetics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sophia Genetics was filed on December 18, 2024 so you should expect the next rating to be made available sometime around December 18, 2025.
Is the Analyst Rating Sophia Genetics (SOPH) correct?
While ratings are subjective and will change, the latest Sophia Genetics (SOPH) rating was a initiated with a price target of $0.00 to $11.00. The current price Sophia Genetics (SOPH) is trading at is $2.98, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
